Detection of drugs and hepatitis C virus in used syringes from a needle exchange in Gothenburg, Sweden
Drug Testing and Analysis · 2024
DOI: 10.1002/dta.3614 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Testing and Analysis, 2024. Verfasst von Moa Andresen Bergström und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Chemistry, Sahlgrenska University Hospital, Gothenburg, Region Västra Götaland, Sweden. Hauptthemen laut MEDLINE: Syringes, Needle-Exchange Programs, Hepatitis C, Substance Abuse, Intravenous. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Folkhälsomyndigheten, Public Health Agency of Sweden.
Abstract (Originalsprache)
People who inject drugs (PWID) are exposed to serious health risks such as lethal overdoses, addiction and infections. The patterns of drug use and the prevalence of hepatitis C virus (HCV) infection vary greatly between and even within countries. Data on drugs used for injection are important to inform PWID of risks and adapt healthcare. This study aimed to determine which substances are injected in Gothenburg, Sweden, and estimate the risk of HCV transmission. A total of 150 syringes handed in at the needle and syringe exchange program (NEP) in Gothenburg over a week in November 2021 were analysed for drug content using liquid chromatography coupled with high‐resolution mass spectrometry. Using a dose‐adjusted comparison, the main drug(s) injected was distinguished from the impurities in the syringes containing several drugs. HCV RNA was quantified by real‐time PCR in an additional set of 150 syringes. Drugs were detected in >99% of analysed syringes, and the most common drugs were amphetamine (81%), followed by buprenorphine (8.0%), heroin (6.7%) and alprazolam (4.6%). Less common findings were testosterone (2.7%), methylphenidate (2.0%), MDMA (0.7%), trenbolone (0.7%) and zopiclone (0.7%). Eleven syringes (7.3%) contained more than one drug. HCV RNA was detected in 13% of the syringes, and one in 10 contained enough to potentially transmit an infection. This study underlines the importance of access to NEPs for PWID to reduce the risks associated with drug injection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Chemistry, Sahlgrenska University Hospital, Gothenburg, Region Västra Götaland, Sweden.
- Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
- Department of Clinical Microbiology, Sahlgrenska University Hospital, Gothenburg, Region Västra Götaland, Sweden.
- Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
- Department of Addiction and Dependency, Sahlgrenska University Hospital, Gothenburg, Region Västra Götaland, Sweden.
ORCID-Profile: Moa Andresen Bergström, Simon B Larsson
Förderung
- Folkhälsomyndigheten
- Public Health Agency of Sweden
Zitieren
APA
Bergström, M. A., Andersson, M. E., & Larsson, S. B. (2024). Detection of drugs and hepatitis C virus in used syringes from a needle exchange in Gothenburg, Sweden. Drug Testing and Analysis. https://doi.org/10.1002/dta.3614
Vancouver
Bergström MA, Andersson ME, Larsson SB. Detection of drugs and hepatitis C virus in used syringes from a needle exchange in Gothenburg, Sweden. Drug Testing and Analysis. 2024. doi:10.1002/dta.3614
BibTeX
@article{Bergstrm2024,
author = {Bergström, Moa Andresen and Andersson, Maria E and Larsson, Simon B},
title = {Detection of drugs and hepatitis C virus in used syringes from a needle exchange in Gothenburg, Sweden},
journal = {Drug Testing and Analysis},
year = {2024},
doi = {10.1002/dta.3614}
}
EUVIMED